This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing BPL-003 Efficacy and Safety for treatment-resistant depression.
Multiple locations, including Birmingham
DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
This study is looking at care and outcomes for people with Attention Deficit or Hyperactivity Disorder. Some participants may receive Control group 1 instead of the study treatment, and direct benefit is not guaranteed.
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
In Aarau
ADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 20 Years to 55 Years
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.